Medication-info.com Search Menu

Bexarotene (Targretin): Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx) Boxed warning
Strength:
75 mg
Brand names:
Drug class:
Active ingredient:

Patient information: uses, side effects, how to take - Bexarotene

What is the most important information I should know about bexarotene capsules?

Bexarotene capsules can cause serious side effects, including major birth defects to an unborn baby, if taken during pregnancy.

For females who can become pregnant:

  • You should avoid becoming pregnant during treatment with bexarotene.
  • Do not take bexarotene capsules if you are pregnant or plan to become pregnant.

  • Your healthcare provider will do a pregnancy test, within one week before you start bexarotene, and each month during treatment with bexarotene to make sure that you are not pregnant.
  • You must use two effective forms of birth control together starting one month before you begin treatment with bexarotene, during treatment, and for one month after stopping bexarotene. Birth control pills (oral contraceptives) and other hormonal forms of birth control may not be effective if used with bexarotene. At least one of the forms of birth control that you choose should not contain hormones. Talk to your healthcare provider about what forms of birth control may be right for you during treatment with bexarotene.
  • You should start taking bexarotene capsules on the second or third day of a normal menstrual period. Follow your healthcare provider’s instructions about when to start bexarotene.
  • Call your healthcare provider right away, if you become pregnant or think that you are pregnant during treatment with bexarotene, and for one month after you stop taking bexarotene capsules.

For males:

  • You must use a condom with female partners who are pregnant, might be pregnant, or who are able to become pregnant, during treatment with bexarotene and for at least one month after your last dose.

What are bexarotene capsules?

Bexarotene capsules is a prescription medicine used to treat the skin problems that happen with a type of cancer called cutaneous T-cell lymphoma (CTCL) after treatment with at least one other type of medicine by mouth or injection, did not work or has stopped working.

It is not known if bexarotene is safe and effective in children.

Who should not take bexarotene capsules?

Do not take bexarotene capsules:

  • if you are pregnant or plan to become pregnant. See “What is the most important information I should know about bexarotene capsules?”
  • if you are allergic to bexarotene or any of the ingredients in bexarotene capsules. See the end of this leaflet for a complete list of ingredients in bexarotene capsules.

Before taking bexarotene capsules, tell your healthcare provider about all of your medical conditions, including if you:

  • have or have had problems with your pancreas, including pancreatitis
  • have or have had gallbladder problems
  • have or have had liver problems
  • have thyroid problems
  • have diabetes
  • have high levels of fats (lipids) called cholesterol or triglycerides in your blood
  • have cataracts or a history of cataracts
  • drink alcohol
  • are pregnant, plan to become pregnant, or think you may be pregnant. See “What is the most important information I should know about bexarotene capsules?”
  • are breastfeeding or plan to breastfeed. It is not known if bexarotene passes into your breast milk. You should not breastfeed during treatment with bexarotene. Talk to your healthcare provider about the best way to feed your baby during treatment with bexarotene.

Tell your healthcare provider about all of the medicines you take, including prescription and over-the counter medicines, vitamins, and herbal supplements. Using bexarotene capsules with certain other medicines can affect each other.

How should I take bexarotene capsules?

  • Take bexarotene capsules exactly as your healthcare provider tells you.
  • Your healthcare provider will tell you how many bexarotene capsules to take each day. Your healthcare provider may change your daily dose of bexarotene as needed to treat your CTCL or if you get certain side effects. You should not change your dose unless your healthcare provider tells you to.

Take your dose of bexarotene capsules 1 time a day with a meal. Your healthcare provider will do blood tests before you start bexarotene and during treatment to check for side effects.

What should I avoid while taking bexarotene capsules?

  • Limit your exposure to sunlight and artificial types of sunlight. Bexarotene capsules can make your skin more sensitive to sunlight and you can get sunburn.
  • Limit the amount of vitamin A that you take during treatment with bexarotene. Large doses of vitamin A may cause side effects that are similar to side effects that can happen in people who take bexarotene capsules.

What are the possible side effects of bexarotene capsules?

Bexarotene capsules can cause serious side effects, including:

  • See “What is the most important information I should know about bexarotene capsules?”
  • Increased levels of fats (lipids) called cholesterol or triglycerides, in your blood are common with bexarotene capsules, but can also be serious. Your healthcare provider may prescribe you medicines to treat high cholesterol or triglycerides levels, reduce your dose, temporarily stop treatment or completely stop treatment with bexarotene if you have this problem.
  • Inflammation of the pancreas (acute pancreatitis). Bexarotene capsules can sometimes cause pancreatitis that comes on suddenly (acute), and that can lead to death. Your risk of developing acute pancreatitis may greater if you:
  • have had pancreatitis in the past o have diabetes that is not controlled
  • high levels of fats in your blood that are not controlled o take certain medicines that can increase the amount of triglycerides in your blood
  • drink large amounts of alcohol
  • have gallbladder problems o take medicines that can harm your pancreas

Tell your healthcare provider right away if you develop signs or symptoms of pancreatitis during treatment with bexarotene capsules, including:

  • nausea that will not go away o vomiting o stomach-area (abdominal) or back pain
  • Liver problems, including liver failure. Bexarotene capsules can cause increased liver function blood test results, or liver problems that can lead to death.
  • Thyroid problems (hypothyroidism) are common with bexarotene.

Your healthcare provider may prescribe thyroid hormone treatment for you if needed.

  • Low white blood cell count is common with bexarotene capsules, but may sometimes be severe.
  • New or worse cataracts. Tell your healthcare provider about any changes in your vision during treatment with bexarotene capsules. You may need to have any eye examination.
  • Risk of low blood sugar in people who have diabetes.

Bexarotene capsules can interact with certain medicines used to treat diabetes, such as insulin, sulfonylurea medicines, and thiazolinedione medicines. If you have diabetes, talk to your healthcare provider about your diabetes medicines and your risk for low blood sugar if you take bexarotene capsules.

The most common side effects of bexarotene capsules include:

  • headache • infection
  • asthenia • stomach-area (abdomen) pain
  • rash • swelling of your hands, arms, feet or legs
  • nausea • dry skin

These are not all the possible side effects of bexarotene capsules. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

How should I store bexarotene capsules?

  • Store bexarotene capsules Store at 20° to 25°C (68° to 77°F). [see USP Controlled Room Temperature].
  • Store the bexarotene capsules bottle away from light, heat, and humidity.
  • The capsules should not be taken after the expiration date printed on the bottle.

Keep bexarotene capsules and all medicines out of the reach of children.

General information about the safe and effective use of bexarotene capsules

Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. Do not use bexarotene capsules for a condition for which it was not prescribed. Do not give bexarotene capsules to other people, even if they have the same symptoms that you have. It may harm them. You can ask your pharmacist or healthcare provider for information about bexarotene capsules that is written for health professionals.

What are the ingredients in bexarotene capsules?

Active ingredient: bexarotene

Inactive Ingredients: butylated hydroxyanisole, polyethylene glycol 400, polysorbate 20 and povidone. The capsule shell contains gelatin, glycerin, sorbitol sorbitan solution and opatint white. The opacode WB black ink contains ferrosoferric oxide, hypromellose, and propylene glycol.

The composition of opatint white contain titanium dioxide.

All the trademarks or registered trademarks are the trademarks or registered trademarks of their respective owners. For more information, call Camber Pharmaceuticals, Inc., at 1-866-495-8330.

Patient Information available at http://camberpharma.com/medication-guides

Manufactured by:

Ascent Pharmaceuticals Inc.

Central Islip, NY 11722

Manufactured for:

Camber Pharmaceuticals, Inc.

Piscataway, NJ 08854

This Patient Information has been approved by the U. S. Food and Drug Administration. Revised: 01/25

About this document

Source: FDA drug labeling via NLM DailyMed · Application number: ANDA 208628 · View the label on DailyMed

Revision date stated in the text: January 2025

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Bexarotene

Rx or OTC
Prescription (Rx)?
  • This drug is available only with a prescription from a licensed healthcare provider.
  • Rx
Boxed warning Yes – this drug has a boxed warning (also called a black box warning), the strongest warning of the FDA.
Drug class Retinoid
Active ingredient Bexarotene 75 mg
Dosage form Capsule
Route Oral
Marketing status listed in the FDA NDC Directory
Company (applicant) ASCENT PHARMS INC
FDA approval ANDA 208628Abbreviated New Drug Application (ANDA) – generic drug Approved September 6, 2024
Therapeutic equivalence (TE) code ABCodes starting with A mean the FDA rates the drug therapeutically equivalent to its reference drug (Orange Book).
Manufacturers 6 labelers list this drug on DailyMed
Packages (NDC)
Package
75 mg – 100 in 1 bottle / 1 in 1 carton NDC 31722-380-01

Source: FDA drug labeling via NLM DailyMed, data as of October 31, 2026. FDA data (DailyMed, Orange Book, Drug Shortages, enforcement reports). Not a substitute for the advice of a doctor or pharmacist.